Acelyrin Inc (NQ: SLRN )
4.780
-0.030
(-0.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Acelyrin Inc
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
What 5 Analyst Ratings Have To Say About Acelyrin
November 28, 2023
Via Benzinga
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Acelyrin, Inc. (NASDAQ:SLRN) Investor Alert: Lawsuit Alleges False and Misleading Statements
December 08, 2023
Via SBWire
Topics
Lawsuit
![](https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://mms.businesswire.com/media/20231130559104/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20231130535685/en/805463/22/business_Wire_Robbins_LLP.jpg)
![](https://mms.businesswire.com/media/20231130923569/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://mms.businesswire.com/media/20231129126673/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20231129913140/en/478343/5/GPM_Logo_Colo.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/11/28/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/28/slrn_0.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3226683a-18cb-4ea7-859a-30a2c09c8f37/small/acelyrin-inc-logo-jpg.jpg)
ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program
November 27, 2023
From ACELYRIN, INC.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/38c8d81f-4a6b-4f23-8411-e6be6a60dda1/small/ld-logo-png.png)
![](https://mms.businesswire.com/media/20231127634618/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.